Summary:
A clinical research study is currently enrolling adults diagnosed with relapsing multiple sclerosis (MS). This study is being conducted to see if an injectable study drug is more effective than an oral medication currently used in treatment.
You may be eligible to join ASCLEPIOS if you:
- Are 18 to 55 years of age
- Have been diagnosed with relapsing multiple sclerosis
Qualified participants will receive study drug and study-related medical care at no cost.